| Title : Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma - Yano_2008_Cancer.Sci_99_2309 |
| Author(s) : Yano H , Kayukawa S , Iida S , Nakagawa C , Oguri T , Sanda T , Ding J , Mori F , Ito A , Ri M , Inagaki A , Kusumoto S , Ishida T , Komatsu H , Inagaki H , Suzuki A , Ueda R |
| Ref : Cancer Sci , 99 :2309 , 2008 |
| Abstract : Yano_2008_Cancer.Sci_99_2309 |
| ESTHER : Yano_2008_Cancer.Sci_99_2309 |
| PubMedSearch : Yano_2008_Cancer.Sci_99_2309 |
| PubMedID: 18771527 |
Yano H, Kayukawa S, Iida S, Nakagawa C, Oguri T, Sanda T, Ding J, Mori F, Ito A, Ri M, Inagaki A, Kusumoto S, Ishida T, Komatsu H, Inagaki H, Suzuki A, Ueda R (2008)
Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma
Cancer Sci
99 :2309
Yano H, Kayukawa S, Iida S, Nakagawa C, Oguri T, Sanda T, Ding J, Mori F, Ito A, Ri M, Inagaki A, Kusumoto S, Ishida T, Komatsu H, Inagaki H, Suzuki A, Ueda R (2008)
Cancer Sci
99 :2309